PNC Financial Services Group Inc. raised its stake in shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report) by 17.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 30,559 shares of the company’s stock after purchasing an additional 4,604 shares during the quarter. PNC Financial Services Group Inc.’s holdings in BlackRock Health Sciences Term Trust were worth $448,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds have also bought and sold shares of the company. Benjamin F. Edwards & Company Inc. raised its stake in shares of BlackRock Health Sciences Term Trust by 24.1% during the fourth quarter. Benjamin F. Edwards & Company Inc. now owns 4,792 shares of the company’s stock worth $70,000 after acquiring an additional 930 shares in the last quarter. Stratos Wealth Advisors LLC purchased a new position in shares of BlackRock Health Sciences Term Trust during the fourth quarter worth approximately $170,000. CWM LLC raised its stake in shares of BlackRock Health Sciences Term Trust by 1,212,300.0% during the fourth quarter. CWM LLC now owns 12,124 shares of the company’s stock worth $178,000 after acquiring an additional 12,123 shares in the last quarter. Pine Valley Investments Ltd Liability Co raised its stake in shares of BlackRock Health Sciences Term Trust by 6.7% during the fourth quarter. Pine Valley Investments Ltd Liability Co now owns 13,088 shares of the company’s stock worth $192,000 after acquiring an additional 822 shares in the last quarter. Finally, B. Riley Wealth Advisors Inc. raised its stake in shares of BlackRock Health Sciences Term Trust by 4.8% during the third quarter. B. Riley Wealth Advisors Inc. now owns 17,363 shares of the company’s stock worth $250,000 after acquiring an additional 796 shares in the last quarter.
BlackRock Health Sciences Term Trust Price Performance
BMEZ stock opened at 15.36 on Friday. BlackRock Health Sciences Term Trust has a one year low of 12.93 and a one year high of 16.59. The company’s 50 day moving average price is 15.10 and its two-hundred day moving average price is 15.38.
BlackRock Health Sciences Term Trust Increases Dividend
Insider Activity at BlackRock Health Sciences Term Trust
In other BlackRock Health Sciences Term Trust news, major shareholder Saba Capital Management, L.P. purchased 46,421 shares of the stock in a transaction on Monday, April 1st. The stock was acquired at an average price of 16.33 per share, with a total value of 758,054.93. Following the completion of the acquisition, the insider now owns 20,538,431 shares in the company, valued at 335,392,578.23. The acquisition was disclosed in a filing with the SEC, which is available at this link.
About BlackRock Health Sciences Term Trust
BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.
Featured Articles
- Five stocks we like better than BlackRock Health Sciences Term Trust
- Stock Sentiment Analysis: How it Works
- Qualcomm Stock: AI-Powered Growth Despite Volatility
- 5 Top Rated Dividend Stocks to Consider
- Salesforce Stock: Meeting Recap, AI Focus, and Forecast
- How to invest in marijuana stocks in 7 steps
- Is CAVA Overextended? A Closer Look at This High-Flying Stock
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.